Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mandiri Herindo Adiperkasa Tbk. (MAHA) vs Merck Tbk. (MERK) Price & Performance

Mandiri Herindo Adiperkasa Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Mandiri Herindo Adiperkasa Tbk. vs Merck Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp141 (market cap 2.33T, 2.7M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is the larger of the two by market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (2.7M versus 37.6K). Which is the better fit depends on your goals.

MAHAMERK
Market Cap
2.33T1.7T
Volume
2.7M37.6K
Lot
27K376
Turnover
378.94M144.47M
Average Price
140.363,842.23
Value
378.94M144.47M
Indicative Equilibrium Price
1423,840
Indicative Equilibrium Volume
207

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MAHA
View details
MERK
View details

About Mandiri Herindo Adiperkasa Tbk.

PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.

Read more on MAHA

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK